65,437 trials
Skin Manifestations
Primary: Number of Participants Who Were a Success With Regard to Worst Post-baseline Tolerability Assessment Scores in Each Category of the Tolerability Assessments (Erythema…
Hypertension
Primary: Maximum Plasma Concentration (Cmax) at Day 1 and Day 8 in 6-11 and 12-17 Year Old Patients — 76.8; 393.3; 82.2; 397.1 ng/ml
Pneumococcal Vaccines
Primary: Pneumococcal OPA Geometric Mean Titers (GMTs) for the 12 Common Serotypes for 13vPnC / 23vPS (Year 1) Versus 23vPS (Year 0) — 148; 148; 125; 80 geometric mean titer
Pancreatic Fistula
Primary: Number of Patients With Pancreatic Fistula — 9; 8 participants
Contraception
Primary: Mean Maximum Concentration (Cmax) of EE Incl. Bioequivalence (BE) Evaluation — 58.5; 61.6 pg/mL
Acute Myeloid Leukemia · Myelodysplastic Syndrome
Primary: Number of Participants With Response — 5; 49; 0; 4 Participants
Stenoses
Primary: Percent of Participants With Treatment Area Primary Patency (TAPP) — 51; 23; 60 Percentage of Participants — p=<0.001
Hypertension
Primary: Change in Mean Sitting Systolic Blood Pressure (msSBP) From Baseline to End of Study (Week 8) — -31.37; -27.99; -30.77; -37.92 mmHg
Prostate Cancer
Primary: To Evaluate the Efficacy of Bevacizumab Plus Erlotinib — 9; 1; 2; 7 participants
Methicillin Resistant Staphylococcus Aureus (MRSA)
Primary: Clinical Outcome in Participants With Baseline Methicillin Resistant Staphylococcus Aureus (MRSA) at End of Study (EOS) for PP Population — 95; 81; 70; 93 Participants…
Invasive Candidiasis
Primary: Proven and Probable Invasive Candidiasis Based on Modified Mycoses Study Group/European Organization for Research and Treatment of Cancer (MSG/EORTC) Criteria. — 9.8…
Vaginal Microflora
Primary: Percentage of Subjects Showing Unfavorable Changes in Primary Microflora — 52.7; 52.9; 60.0 Percentage of Participants
Helicobacter Pylori Infection
Primary: Number of Participants in Which H. Pylori Was Eradicated — 94; 99 participants
Chronic Obstructive Pulmonary Disease
Primary: Forced Expiratory Volume in One Second (FEV1) Area Under Curve (AUC) 0-24 Hours on Day 14 — 1.827; 1.664 Liters
Rheumatoid Arthritis
Primary: American College of Rheumatology 20% (ACR20) Response at Week 12 — 51.1; 25.9 percentage of subjects